How to invest wisely in 2018?
At the recent members’ conference, I presented my insights on the markets and how I think it should affect the allocation of our portfolio, if at all. Here are the main points: Although many feel…
Search Results for APVO
Aptevo Therapeutics – huge potential with high risk
I bought Aptevo Therapeutics (APVO) to the spin-off portfolio at $2.40. Note: This is a biotechnology company with high risk profile. * * * Six months ago, I bought shares of Nuvectra Corporation (NVTR) –…